Attention deficit/hyperactivity disorder across the lifespan

TE Wilens, J Biederman… - Annual review of medicine, 2002 - annualreviews.org
▪ Abstract Attention deficit/hyperactivity disorder (ADHD) is the most common
neurobehavioral disorder presenting for treatment in youth. ADHD is often chronic with …

Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications

ML Wolraich, CJ Wibbelsman, TE Brown… - …, 2005 - publications.aap.org
Attention-deficit/hyperactivity disorder (ADHD) is the most common mental disorder in
childhood, and primary care clinicians provide a major component of the care for children …

Updated European Consensus Statement on diagnosis and treatment of adult ADHD

JJS Kooij, D Bijlenga, L Salerno, R Jaeschke… - European …, 2019 - cambridge.org
Background Attention-deficit/hyperactivity disorder (ADHD) is among the most common
psychiatric disorders of childhood that often persists into adulthood and old age. Yet ADHD …

Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder

J Biederman, T Spencer - Biological psychiatry, 1999 - Elsevier
This review revisits the thesis that a dysregulation of the central noradrenergic networks may
underlie the pathophysiology of ADHD. We review the pertinent neurobiological and …

[图书][B] Adult ADHD: Diagnostic assessment and treatment

JJS Kooij - 2012 - books.google.com
Adult ADHD: Diagnostic Assessment and Treatment, Third Edition covers not only diagnostic
assessment, but also comorbidity patterns as well as differential diagnosis of ADHD with for …

Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial …

S Akhondzadeh, MR Mohammadi, M Khademi - BMC psychiatry, 2004 - Springer
Background Attention-deficit hyperactivity disorder is an early-onset, clinically heterogenous
disorder of inattention, hyperactivity, and impulsiveness. The diagnosis and treatment of …

Non–stimulant medications in the treatment of ADHD

T Banaschewski, V Roessner, RW Dittmann… - European child & …, 2004 - Springer
Background Stimulants are the first–line medication in the psychopharmacological treatment
of attention–deficit hyperactivity disorder (ADHD). However, 10 to 30% of all children and …

Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder

J Biederman, T Spencer, T Wilens - International Journal of …, 2004 - academic.oup.com
There is a substantial body of literature documenting the efficacy of multiple unrelated
pharmacological agents in attention-deficit hyperactivity disorder (ADHD) individuals …

Psychiatric medication‐induced obesity: a review

TL Schwartz, N Nihalani, S Jindal, S Virk… - Obesity …, 2004 - Wiley Online Library
A majority of psychiatric medications are known to generate weight gain and ultimately
obesity in some patients. There is much speculation about the prevalence of weight gain …

Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder

JH Newcorn, TJ Spencer, J Biederman… - Journal of the American …, 2005 - Elsevier
OBJECTIVE:: To examine (1) moderating effects of oppositional defiant disorder (ODD) on
attention-deficit/hyperactivity disorder (ADHD) treatment response and (2) responses of …